Literature DB >> 27241778

[Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].

K Lenz1, R Buder2, G Lohr2, P Piringer2, M Voglmayr2.   

Abstract

Renal failure is a serious complication in patients with advanced cirrhosis. It occurs in about 20 % of patients hospitalized with cirrhosis. In about 70 % it is caused by prerenal failure, and in 30 % it is due to intrarenal causes. In about 70 % of patients with rperenal failure, renal function can be restored with fluid replacement, but the remaining 30 % are unresponsive to volume expansion. Minor increase in serum creatinine have been shown to be clinically relevant and can adversely affect survival. Therefore early efforts should be made to avoid precipitation of renal failure.Hepatorenal syndrome (HRS) is a  fully reversible impairment of renal function in patients with cirrhosis unresponsive to volume expansion characterized by an acute progressive decrease in kidney function (serumcreatinin > 1,5 mg/dl) - type 1 HRS, whereas type 2 HRS features a decrease in kidney function over a long time, mostly in patients with refractory ascites. Therapy with vasoconstrictors like terlipressin to reverse splanchnic vasodilation, together with albumin is effective in 30-50 % of patients with HRS 1 and improves survival. The only effective longterm therapy is livertransplantation. An improvement of kidney fuction before transplantation is associated with a better outcome and posttransplant kidney function.

Entities:  

Keywords:  Ascites; Hepatitis; Kidney diseases; Liver diseases; Peritonitis

Mesh:

Substances:

Year:  2016        PMID: 27241778     DOI: 10.1007/s00063-016-0177-5

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  41 in total

1.  Causes of renal failure in patients with decompensated cirrhosis and its impact in hospital mortality.

Authors:  Grazielle Cerqueira de Carvalho; Catarina de Andrade Regis; Jamile Rosário Kalil; Liv Aparício Cerqueira; Daniel Silva Barbosa; Marina Pamponet Motta; Marília da Silva Nery; Maria Alice Pires Soares; Claudio Celestino Zollinger; Paulo Lisboa Bittencourt
Journal:  Ann Hepatol       Date:  2012 Jan-Feb       Impact factor: 2.400

Review 2.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

3.  The cardiorenal link in advanced cirrhosis.

Authors:  Aleksander Krag; Flemming Bendtsen; Andrew K Burroughs; Søren Møller
Journal:  Med Hypotheses       Date:  2012-04-24       Impact factor: 1.538

Review 4.  Endothelin and other mediators in the pathophysiology of portal hypertension.

Authors:  A L Gerbes; V Gülberg; M Bilzer
Journal:  Digestion       Date:  1998-07       Impact factor: 3.216

5.  The effect of octapressin on renal and intrarenal blood flow in cirrhosis of the liver.

Authors:  M C Kew; R R Varma; D J Sampson; S Sherlock
Journal:  Gut       Date:  1972-04       Impact factor: 23.059

6.  Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease.

Authors:  M H Koppel; J W Coburn; M M Mims; H Goldstein; J D Boyle; M E Rubini
Journal:  N Engl J Med       Date:  1969-06-19       Impact factor: 91.245

7.  Acute kidney injury in decompensated cirrhosis.

Authors:  Cynthia D Tsien; Rania Rabie; Florence Wong
Journal:  Gut       Date:  2012-05-25       Impact factor: 23.059

8.  Terlipressin, a provasopressin drug exhibits direct vasoconstrictor properties: consequences on heart perfusion and performance.

Authors:  Frédérique Ryckwaert; Anne Virsolvy; Aurélie Fort; Brigitte Murat; Sylvain Richard; Gilles Guillon; Pascal H Colson
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

9.  Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival.

Authors:  Karl Oettl; Ruth Birner-Gruenberger; Walter Spindelboeck; Hans Peter Stueger; Livia Dorn; Vanessa Stadlbauer; Csilla Putz-Bankuti; Peter Krisper; Ivo Graziadei; Wolfgang Vogel; Carolin Lackner; Rudolf E Stauber
Journal:  J Hepatol       Date:  2013-06-25       Impact factor: 25.083

10.  Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis.

Authors:  Vanessa Stadlbauer; Vanessa P Stadlbauer; Gavin A K Wright; Murad Banaji; Ashis Mukhopadhya; Rajeshwar P Mookerjee; Rajeshwar Mookerjee; Kevin Moore; Rajiv Jalan
Journal:  Gastroenterology       Date:  2008-01       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.